Equillium Presents Positive Interim Clinical Data of Itolizumab in First-line Treatment of Acute Graft-Versus-Host Disease at the 2021 Transplantation…
stemadminBenefits Of Stem CellsNo comments

LA JOLLA, Calif., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Equillium, Inc.(Nasdaq: EQ), a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders, presented interim data from the EQUATE clinical trial supporting itolizumabs potential as a first-line treatment for acute graft-versus-host disease (aGVHD). The study, described in the late-breaking oral presentation titled Preliminary Safety and Efficacy of Itolizumab, A Novel Targeted Anti-CD6 Therapy, in Newly Diagnosed Severe Acute Graft-Versus-Host Disease: Interim Results from Equate Study, was presented earlier today by John Koreth, MBBS, DPhil, Associate Professor of Medicine, Harvard Medical School, Director of Translational Research Stem Cell Transplantation, Dana-Farber Cancer Institute, at the 2021 TCT Meetings Digital Experience

Read more
Stem Cell Manufacturing Market Improvement Status (2021-2027) By Analyzing the Performance of Various Competitors: Thermo Fisher Scientific, Merck…
stemadminBenefits Of Stem CellsNo comments

The Stem Cell Manufacturing Market research report published by the data bridge market research, offers a comprehensive analysis of growth trends prevailing in the in this swiftly changing market place, businesses must take up market research report. This report also provides definitive data concerning market, size, commercialization aspects and revenue forecast of the industry

Read more
Science of Aging is Focus of New Bakar Research Institute – UCSF News Services
stemadminBenefits Of Stem CellsNo comments

Leanne Jones, PhD, will join UCSF from UCLA to lead the new Bakar Aging Research Institute. UC San Francisco is launching the Bakar Aging Research Institute (BARI), a scientific community that aims to translate breakthroughs in aging research across many disciplines into new approaches and treatments that help people remain healthy and vibrant in later life

Read more
Global Regenerative Medicine Partnering Deals, Terms and Agreements Directory 2014-2020: Analysis of the Structure of Regenerative Medicine Agreements…
stemadminBenefits Of Stem CellsNo comments

Bloomberg (Bloomberg) -- Stefan Qin was just 19 when he claimed to have the secret to cryptocurrency trading.Buoyed with youthful confidence, Qin, a self-proclaimed math prodigy from Australia, dropped out of college in 2016 to start a hedge fund in New York he called Virgil Capital.

Read more
Energy drinks may damage the heart, researchers warnshould the FDA get involved? – Cardiovascular Business
stemadminBenefits Of Stem CellsNo comments

Drinking certain energy drinks may cause significant damage to the heart, according to new findings published in Food and Chemical Toxicology. Because the consumption of these beverages is not regulated and they are widely accessible over the counter to all age groups, the potential for adverse health effects of these products is a subject of concern and needed research, lead researcher Ivan Rusyn, MD, PhD, a professor at Texas A&M University in College Station, said in a prepared statement. Rusyn et al.

Read more
Man who wants to live for 180 years spends Rs 18 lakh to re-inject his own stem cells – Times Now
stemadminBenefits Of Stem CellsNo comments

Dave Asprey&nbsp | &nbspPhoto Credit:&nbspTwitter A man who is determined to live until he is 180 years old says that his bizarre methods will soon be as popular as mobile phones. American millionaire tech entrepreneur Dave Asprey, 47, believes he will live to the year 2153 'at least' by using techniques such as sitting in a cold cryotherapy chamber and intermittent-fasting. Dave coined the term 'Biohacking' to describe his methods of turning back the biological clock

Read more

Theme: Illdy.